Vietnam Pleads For Greater Drug MNC Investment In Local Industry
This article was originally published in PharmAsia News
Executive Summary
Vietnam's Ministry of Health is asking for help from multinational pharmaceutical companies to step up their investments in the country and support locally made products. Although Vietnam issued licenses in 2008 to 37 foreign direct-investment projects, only 25 were implemented and only a single additional investment license was granted for local drug production. The ministry noted the great potential of Vietnam's pharma sector, yet foreign investments in the industry still account for a relatively small amount of the FDI, down 25 percent from the previous year. Foreign drug makers appear interested only in seeking local suppliers for their products rather than investing in local manufacturing plants, the director of the ministry's drug administration said. (Click here for more
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.